Emory University

Jon Serody, M.D.

Dr. Laurie is currently a Patent Examiner, AU 1643, at the USPTO

Fall 2020 Special Topics in Immunology – Johnson C. Smith University

Spring 2020 Introduction to Biology I – Johnson C. Smith University

Vincent BG- File DM- McKinnon KP- Moore DT- Frelinger JA- Collins EJ- Ibrahim JG- Bixby L- Reisdorf S- Laurie SJ- Park YA- Anders CK- Collichio FA- Muss HB- Carey LA- van Deventer HW- Dees EC- Serody JS. Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors. Journal of immunology (Baltimore- Md. : 1950). 2023 May 19;. PMID: 37204246. 

Anders CK- Woodcock MG- Van Swearingen AED- Moore DT- Sambade MJ- Laurie S- Robeson A- Kolupaev O- Cuaboy LA- Garrett AL- McKinnon K- Cowens K- Bortone D- Calhoun BC- Wilkinson AD- Carey L- Jolly T- Muss H- Reeder-Hayes K- Kaltman R- Jankowitz R- Gudena V- Olajide O- Perou C- Dees EC- Vincent BG- Serody JS. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.. Journal for immunotherapy of cancer. 2022 Feb;10(2). 10.1136/jitc-2021-003427. 35121644. . 

Bruce DW, Kolupaev O, Laurie SJ, Bommiasamy H, Stefanski H, Blazar BR, Coghill JM, Serody JS. Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD. Blood Adv. 2021 Nov 23;5(22):4578-4589. PMCID: PMC8759141.

Xu N- Palmer DC- Robeson AC- Shou P- Bommiasamy H- Laurie SJ– Willis C- Dotti G- Vincent BG- Restifo NP- Serody JS. STING agonist promotes CAR T cell trafficking and persistence in breast cancer.. The Journal of experimental medicine. 2021 Feb 1;218(2). 10.1084/jem.20200844. 33382402. pmc-id: PMC7780733